Vesicourethral dysfunction is very frequent in multiple sclerosis (MS) and has functional consequences for patients' quality of life and also an organic impact following complications of the neurogenic bladder on the upper urinary tract. While the functional impact and its management are well documented in the literature, the organic impact remains underestimated and there are no consensual practical guidelines for the screening and prevention of MS neurogenic bladder complications. The aim of this review of the literature, focused on identifying the risk factors of urinary tract complications in MS, is to put forward well informed considerations to help in the definition of practical guidelines for the follow-up of the neurogenic bladder in MS in order to improve its prevention and patient management. Four main risk factors have been identified for upper urinary tract damage: the duration of MS, the presence of an indwelling catheter, high-amplitude neurogenic detrusor contractions and permanent high detrusor pressure. Detrusor-sphincter dyssynergia, age over 50 and male sex may form three additional risk factors. Recommendations for long-term urological follow-up, taking into account these specific risks are constructed according to the procedures recommended by the French Health Authorities. Multiple Sclerosis 2007; 13: 915-928. http://msj.sagepub.com
Anaes.Guide to literature analysis and scoring ofl recommendations. ANAES , January 2000. Retrievedflrom:http//www.anaes.flr
2.
Amarenco G. , Kerdraon J. Bladder and sphincter dysflunction in multiple sclerosis. Clinical, urodynamical and neurophysiologic study ofl 225 cases . Rev Neurol1995; 151: 722-30 .
3.
Andersen JT , Bradley WEAbnormalities ofl detrusor and sphincter flunction in multiple sclerosis . Br J Urol1976; 48: 193-98 .
4.
Andrews KL , Husmann DABladder dysflunction and management in multiple sclerosis . Mayo Clin Proc1997; 72: 1176-83 .
5.
Awad S. , Gajewski J. , Sogbein S. , Murray TJ , Field CARelationship between neurological and urological status in patients with multiple sclerosis . J Urol1984; 132: 499-502 .
6.
Bakke A. , Myhr KM , Gronning M. , Nyland H.Bladder, bowel and sexual dysflunction in patients with multiple sclerosis - a cohort study . Br J Urol1996; 179: 61 .
7.
Blaivas JG , Bhimani G. , Labib KLVesicourethral dysflunction in multiple sclerosis . J Urol1979; 122: 342-47 .
8.
Bemelmans B. , Hommes O. , Van Kerrebroek P , Doesburg WH , Debruyne FMEvidence flor early tract dysflunction in clinically silent multiple sclerosis . J Urol1991; 145: 1219-24 .
9.
Betts C. , D'Mellow M. , Fowler C.Urinary symptoms and the neurological fleatures ofl bladder dysflunction in multiple sclerosis . J Neurol Neurosurg Psychiatry1993; 56: 245-50 .
de Ridder D. , Vermeulen C. , de Smet E. , Van Poppel H. , Ketelaer P. , Baert L.Clinical assessment ofl pelvic floor dysflunction in multiple sclerosis: urodynamic and neurological correlates . Neurourol Urodyn1998; 17: 53742 .
12.
Eardley I. , Nagendran K. , Lecky B. , Chapple CR , Kirby RS , Fowler CJNeurophysiology ofl the striated urethral sphincter in multiple sclerosis . Br J Urol1991; 68: 81-88 .
13.
Gallien P. , Robineau S. , Nicolas B. , Le Bot MP , Brissot R. , Verin M.Vesicourethral dysflunction and urodynamic findings in multiple sclerosis: a study ofl 149 cases . Arch Phys Med Rehabil1998; 79: 255-57 .
14.
Gallien P. , Nicolas B. , Robineau S. , Le Bot MP , de Crouy AC , Durufle A. et al. Urological complications in multiple sclerosis: study ofl risk flactors . Ann Réadaptation Méd Phys1998; 41: 155-58 .
15.
Giannantoni A. , Sciviletto G. , Di Stasi SM, Grasso MG, Vespasiani G, Castellano V. Urological dysflunctions and upper urinary tract involvement in multiple sclerosis patients . Neurourol Urodyn1998; 17: 89-98 .
16.
Goldstein I. , Siroky M. , Sax S. , Krane RJNeuro-urologic abnormalities in multiple sclerosis . J Urol1982; 128: 541-45 .
17.
Gonor S. , Caroll D. , Metcalfe J.Vesical dysflunction in multiple sclerosis . Urology1985; 25: 429-31 .
18.
Henessey A. , Robertson NP , Swingler R. , Compston DAUrinary, flaecal and sexual dysflunction in patients with multiple sclerosis . J Neurol1999; 246: 1027-32 .
19.
Kasabian NG , Krause I. , Brown WE , Khan Z. , Nagler HMFate ofl upper urinary tract in multiple sclerosis . Neurourol Urodyn1995; 14: 81-85 .
20.
Koldewijn EL , Hommes OR , Lemmens WA , Debruyne FM , Van Kerrebroeck PE.Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis . J Urol1995 ; 154: 169-73 .
21.
Philp T. , Read J. , Higson R.The urodynamic characteristics ofl multiple sclerosis . Br J Urol1981; 53: 672-75 .
22.
Porru D. , Campus G. , Garau A. , Sorgia M. , Pau AC , Spinici G.Urinary tract dysflunction in multiple sclerosis: is there a relation with disease-related parameters?Spinal Cord1997 ; 35: 33-36 .
23.
Blaivas J. , Bhimani G. , Labib K.Vesico-urethral dysflunction in multiple sclerosis . J Urol1979; 122: 342-47 .
24.
Phadke JGSurvival pattern and cause ofl death in patients with multiple sclerosis: results flrom an epidemiological survey in north-east Scotland . J Neurol Neurosurg Psychiatry1987; 50: 523-31 .
25.
Litwiller SE , Frohman M. , Zimmern PEMultiple sclerosis and the urologist . J Urol1999; 161: 743-57 .
26.
Leboeuf L. , Gousse AEMultiple sclerosis. In C orcos J , Schick E eds. Textbook of neurogenic bladder. Adults and children . Martin Dunitz , 2004: 275-92.
27.
Mayo M. , Chetner M.Lower urinary tract dysflunction in multiple sclerosis . Urology1992; 39: 67-70 .
28.
Sliwa JA , Bell HK , Mason KD , Richard MG , Nanninga J. , Cohen B.Upper urinary tract abnormalities in multiple sclerosis patients with urinary symptoms . Arch Phys Med Rehabil1996 ; 77: 247-51 .
29.
Giannantoni A. , Sciviletto G. , Di Stasi SM , Grasso MG , Finazzi Agro E. , Collura G. et al. Lower urinary tract dysflunction and disability status in patients with multiple sclerosis . Arch Phys Med Rehabil1999; 80: 43741 .
30.
Abrams P. , Cardozo L. , Fall M. , Griffiths D. , Rosier P. , Ulmsten U.The standardisation ofl terminology ofl lower urinary tract flunction: report flor the standardisation subcommittee ofl the International Continence Society . Neurourol Urodyn2002; 21: 167-78 .
31.
Cianco S. , Mutchnik S. , Rivera V. , Boone TBUrodynamic pattern changes in multiple sclerosis . Urology2001; 57: 239-45 .
32.
Petersen T. , Petersen E.Neuro-urodynamic evaluation ofl voiding dysflunction in multiple sclerosis . Acta Neurol Scand1984 ; 69: 402-11 .
33.
Sirls L. , Zimmern P. , Leach G.Role ofl limited evaluation and aggressive medical management in multiple sclerosis: a review ofl 113 patients . J Urol1994; 151: 94650 .
34.
Araki I. , Matsui M. , Ozawa K. , Takeda M. , Kuno S.Relationship ofl bladder dysflunction to lesion site in multiple sclerosis . J Urol2003; 169: 1384-87 .
35.
Kirchlof K. , Fowler CJThe value ofl Kurtzke Functional Systems scales in predicting incontinence bladder emptying . Spinal Cord2000; 38: 409-13 .
36.
Kragt JJ , Hoogevorst EL , Uitdehaag BM , Polman CHRelation between objective and subjective measures ofl bladder dysflunction in multiple sclerosis . Neurology2004; 63: 1716-18 .
37.
Kim YH , Goodman C. , Omessi E. , Rivera V. , Kattan MW , Boone TBThe correlation ofl urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis . J Urol1998 ; 159: 972-76 .
38.
Pozzilli C. , Grasso M. , Bastianello S. , Anzini A. , Salvetti M. , Bozzao L. et al. Structural brain correlates ofl neurological abnormalities in multiple sclerosis . Eur Neurol1992; 32: 228-30.36.
39.
Summers JLNeurogenic bladder in the woman with multiple sclerosis . J Urol1978; 120: 555-56 .
40.
Schoenberg HW , Gutrich J. , Banno J.Urodynamic pattern in multiple sclerosis . J Urol1979; 122: 648-50 .
41.
Piazza D. , Diokno A.Review ofl neurogenic bladder in multiple sclerosis . Urology1979; 14: 33-35 .
42.
Mac Guire E , Sanastano J.Urodynamic findings and long term outcome management ofl patients with multiple sclerosis induced lower urinary tract dysflunction . J Urol1984; 132: 713-15 .
43.
Hinson JL , Boone TBUrodynamics and multiple sclerosis . Urol Clin N Am1996; 23: 475-81 .
44.
Amarenco G. , Bosc S. , Boiteau F.Urological complications ofl multiple sclerosis. 180 cases . Presse Méd1996; 25: 1007-10 .
45.
Barbalias GA , Nikiforidis G. , Liatsikos ENVesicourethral dysflunction associated with multiple sclerosis: clinical and urodynamic perspectives . J Urol1998; 160: 106-11 .
46.
Blaivas J. , Barbalias G.Detrusor external sphincter dyssynergia in men with multiple sclerosis: an ominous urologic condition . J Urol1984 ; 131: 91-94 .
de Sèze M. , Shao E. , Joseph PANosocomial urinary inflection and patients with a neurogenic bladder in rehabilitation . Méd Mal Inf2003; 33: 298s-310s .
49.
Botto H.Nosocomial urinary inflection: consensus report 2002 . Med Mal Inf2003; 33: 370-75 .
50.
National Institute on Disability and Rehabilitation Research Consensus Statement (NIDRR).The prevention and management ofl urinary tract inflections among people with spinal cord injuries . J Am Paraplegia Soc1992; 15: 194-204 .
51.
Joseph P. , de Sèze M.Sphincter and bladder dysflunction in multiple sclerosis . Rev Neurol2001; 89: 1051-59 .
52.
de Ridder D. , Van Poppel H. , Demont-y L. , D'Hooghe B. , Gonsette R. , Carton H. et al. Bladder cancer in patients with multiple sclerosis treated with cyclophosphamide . J Urol1998; 159: 1881-84 .
53.
Van Poppel H. , Stessens R. , de Vos R. , van Damme B.Isolated condyloma acuminatum ofl the bladder in a patient with multiple sclerosis: etiological and pathological considerations . J Urol1986 ; 136: 1071-73 .
54.
Wiedemann A. , Diekmann WP , Holtmann G. , Kracht H.Report ofl a case with giant condyloma (Buschke-Lowenstein tumor) localized in the bladder . J Urol1995 ; 154: 1222-24 .
55.
Esteve J. , Kricker A. , Ferlay J. , Parkin DMFacts and figures ofl cancer in the European Community. International Agency flor Research onCancer, 1993.
56.
Panneck J.Transitional cell carcinoma in patients with spinal cord injury . Spinal Cord2000; 38: 661-68 .
57.
Lawrenson R. , Wyndaele JJ , Vlachonikolis I. , Farmer C. , Glickman S.Renal flailure in patients with neurogenic lower urinary tract dysflunction . Neuroepidemiology2001; 187: 138-43 .
58.
Samellas X. , Rubin B.Management ofl upper urinary tract complications in multiple sclerosis by means ofl urinary diversion to ileal conduit . J Urol1965; 95; 548 .
59.
Leibowitz U. , Kahana E. , Jackson SG , Alter M.The cause ofl death in multiple sclerosis. In Leibowitz U ed. Progress in multiple sclerosis: research and treatment. Academic Press , 1972: 196-209.
60.
Soden RJ , Walsh J. , Middleton JW , Craven ML , Rutkowski SB , Yeo JDCauses ofl death aflter spinal cord injury: a fiflty year investigation . Spinal Cord1998; 36: 266-74 .
61.
Guyatt GH , Sacket DL , Sinclair JC , Hayward R. , Cook DJ , Cook RJflor the Evidence-Based Medicine Working Group. IX. A method flor grading health care recommendations . JAMA1995; 22: 1800-804 .
62.
Bonniaud V. , Jackowski D. , Parratte B. , Paulseth R. , Grad S. , Margetts P.Quality ofl lifle in multiple sclerosis patients with urinary disorders: discriminative validation ofl the English version ofl Qualiveen . Qual Life Res2005; 14: 425-31 .
Anderson KE , Appell R. , Cardozo L. , Chapple C. , Drutz H. , Fourcroy J. et al. Pharmacological treatment ofl urinary incontinence. In A brams P , Cardozo L , Khoury S , Wein A eds. Incontinence, vol 2. Management. Health Publication , 2005: 808-54.
65.
Chancellor MB , Blaivas JGMultiple sclerosis. In Problems in urology, Volume 7, no. 1. JB Lippincott Company , 1993: 15-33.
